Welgene Biotech Co.,Ltd.
6661.TWO
Price:
$18.8
Market Cap:
$438.12M
Welgene Biotech Co.,Ltd. provides genetic testing services. The company offers research services, including sequencing, microarray, qPCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and Cytoscan, an array-based comparative genomic hybridization. It also provides reagents, consumable supplies, and instruments, as well as software services. The company was founded in 2003 and is based in Taipei City, Taiwan.
Industry
Medical - Diagnostics & Research
IPO Date
2017-10-23
Stock Exchange
TWO
Ticker
6661.TWO
PE Ratio
[268.57]
ROE
[0.80%]
Current Ratio
[2.51]
Dividend Yield
[0%]
Enterprise Value
[407.30M]
Dividend History
The ROE as of December 2025 (TTM) for Welgene Biotech Co.,Ltd. (6661.TWO) is 0.80%
According to Welgene Biotech Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is 0.80%. This represents a change of 330.42% compared to the average of 0.19% of the last 4 quarters.
Welgene Biotech Co.,Ltd. (6661.TWO) Historical ROE (quarterly & annually)
How has 6661.TWO ROE performed in the past?
The mean historical ROE of Welgene Biotech Co.,Ltd. over the last ten years is 6.59%. The current 0.80% ROE has changed -87.82% with respect to the historical average. Over the past ten years (40 quarters), 6661.TWO's ROE was at its highest in in the September 2018 quarter at 5.34%. The ROE was at its lowest in in the March 2024 quarter at -1.98%.
Average
6.59%
Median
7.50%
Minimum
-0.91%
Maximum
12.32%
Welgene Biotech Co.,Ltd. (6661.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of Welgene Biotech Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 426.31%
Maximum Annual ROE = 12.32%
Minimum Annual Increase = -142.40%
Minimum Annual ROE = -0.91%
| Year | ROE | Change |
|---|---|---|
| 2024 | 0.38% | -142.40% |
| 2023 | -0.91% | -128.83% |
| 2022 | 3.14% | -28.89% |
| 2021 | 4.42% | -62.49% |
| 2020 | 11.79% | -4.32% |
| 2019 | 12.32% | 7.10% |
| 2018 | 11.51% | 8.68% |
| 2017 | 10.59% | 426.31% |
| 2016 | 2.01% | -81.15% |
| 2015 | 10.67% | -42.30% |
Welgene Biotech Co.,Ltd. (6661.TWO) Average ROE
How has 6661.TWO ROE performed in the past?
The current ROE of Welgene Biotech Co.,Ltd. (6661.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.87%
5-year avg
3.77%
10-year avg
6.59%
Welgene Biotech Co.,Ltd. (6661.TWO) ROE vs. Peers
How is 6661.TWO’s ROE compared to its peers?
Welgene Biotech Co.,Ltd.’s ROE is greater than Taiwan Advanced Nanotech Inc. (-21.37%), greater than UniPharma Co., Ltd. (-14.49%), greater than EPS Bio Technology Corp. (-4.75%), greater than DuoGenic StemCells corporation (-248.08%), greater than Sunder Biomedical Tech. Co., Ltd. (-1.35%), greater than Pharmigene, Inc. (-22.90%), less than A-SPINE Asia Co., Ltd. (3.71%), greater than Sofiva Genomics Co.,Ltd. (-1.13%), greater than Health & Life Co., Ltd. (-3.67%), less than Feng Chi Biotech Corp. (6.61%),
| Company | ROE | Market cap |
|---|---|---|
| -21.37% | $484.03M | |
| -14.49% | $427.79M | |
| -4.75% | $404.60M | |
| -248.08% | $679.06M | |
| -1.35% | $514.20M | |
| -22.90% | $524.90M | |
| 3.71% | $531.43M | |
| -1.13% | $644.56M | |
| -3.67% | $530.97M | |
| 6.61% | $283.35M |
Build a custom stock screener for Welgene Biotech Co.,Ltd. (6661.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Welgene Biotech Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Welgene Biotech Co.,Ltd. (6661.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Welgene Biotech Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Welgene Biotech Co.,Ltd.'s ROE?
How is the ROE calculated for Welgene Biotech Co.,Ltd. (6661.TWO)?
What is the highest ROE for Welgene Biotech Co.,Ltd. (6661.TWO)?
What is the 3-year average ROE for Welgene Biotech Co.,Ltd. (6661.TWO)?
What is the 5-year average ROE for Welgene Biotech Co.,Ltd. (6661.TWO)?
How does the current ROE for Welgene Biotech Co.,Ltd. (6661.TWO) compare to its historical average?